Diatrizoate Meglumine+diatrizoate Sodium
About Diatrizoate Meglumine+diatrizoate Sodium
Diatrizoate Meglumine+diatrizoate Sodium is used as a radiopaque contrast agent for X-ray and fluoroscopic imaging. It aids in visualizing the gastrointestinal tract, blood vessels, urinary tract, and other internal structures. It helps diagnose conditions such as blockages, tumors, and abnormalities in various organs.
Diatrizoate Meglumine+diatrizoate Sodium is a combination medication. It contains diatrizoate meglumine and diatrizoate sodium. These are iodinated contrast agents that effectively absorb X-rays due to their high iodine content, making targeted organs or blood vessels appear opaque for clearer imaging. Being water soluble, they mix with body fluids, enhancing contrast in X-rays, CT scans, and fluoroscopy for accurate diagnosis.
Sometimes, you may experience side effects like nausea, or flushing. Most of these side effects gradually resolve over time and do not require medical attention. However, please consult the doctor if any of these side effects persist or worsen.
Inform your doctor if you are pregnant or breastfeeding before using it. Diatrizoate Meglumine+diatrizoate Sodium may cause dizziness in some individuals. Therefore, do not drive or operate heavy machinery until you know how it affects you. Diatrizoate Meglumine+diatrizoate Sodium is safe for children when used as directed by the doctor. It is unknown whether alcohol interacts with Diatrizoate Meglumine+diatrizoate Sodium. However, as a precautionary measure, it is best to avoid alcohol to prevent potential side effects. Inform your doctor about any pre-existing medical conditions and all the medications you are taking before receiving Diatrizoate Meglumine+diatrizoate Sodium to minimize the risk of potential side effects.
Uses of Diatrizoate Meglumine+diatrizoate Sodium
• X-ray and CT Scans: Diatrizoate Meglumine+diatrizoate Sodium enhance visibility in radiographic examinations, helping doctors diagnose conditions more accurately.
• Gastrointestinal Studies: Diatrizoate Meglumine+diatrizoate Sodium used when barium sulfate is not suitable, particularly for imaging the esophagus, stomach, intestines, and colon.
• Angiography: Diatrizoate Meglumine+diatrizoate Sodium helps visualize blood vessels to detect blockages or abnormalities.
• Urography: Diatrizoate Meglumine+diatrizoate Sodium is used to examine the urinary tract, including the kidneys and bladder.
Medicinal Benefits
Diatrizoate Meglumine+diatrizoate Sodium belongs to the class of medications called radiopaque contrast agents. It is a combination of two drugs, diatrizoate meglumine and diatrizoate sodium. It is used as a radiopaque contrast agent for X-ray and fluoroscopic imaging. It aids in visualizing the gastrointestinal tract, blood vessels, urinary tract, and other internal structures. It helps diagnose conditions such as blockages, tumors, and abnormalities in various organs. It works effectively by absorbing X-rays due to their high iodine content, making targeted organs or blood vessels appear opaque for more precise imaging. Being water soluble, they mix with body fluids, enhancing contrast in X-rays, CT scans, and fluoroscopy for accurate diagnosis.
Directions for Use
Storage
Side Effects of Diatrizoate Meglumine+diatrizoate Sodium
- Nausea
- Flushing
Drug Warnings
Diatrizoate Meglumine+diatrizoate Sodium should not be administered to individuals if they are allergic to it or its ingredients. Inform your doctor if you have a history of blood clots, as this medication may increase the risk of serious conditions like heart attack or stroke. Spinal cord procedures with contrast agents carry risks of paralysis or death if injected into spinal cord blood vessels. Therefore, discuss the risks with your doctor before the procedure. Inform your doctor if you have a history of brain bleeding, as using Diatrizoate Meglumine+diatrizoate Sodium in such cases has been linked to seizures and fatal outcomes. Patients with multiple myeloma are at a higher risk of severe kidney complications, including fatality. Consult your doctor to assess the risks before using it. Please inform your doctor if you are pregnant or breastfeeding before using Diatrizoate Meglumine+diatrizoate Sodium. Diatrizoate Meglumine+diatrizoate Sodium may cause dizziness in some individuals. Therefore, avoid driving or operating heavy machinery until you know how it affects you. Inform your doctor if you have any pre-existing medical conditions and if you are taking any other medications to rule out potential interactions.
Drug Interactions
Drug-Drug Interactions: Diatrizoate Meglumine+diatrizoate Sodium may interact with anti-viral medications (adefovir), antibiotics (amikacin, bacitracin), chemotherapy agents (cisplatin), immunosuppressants (cyclosporine), NSAIDs (celecoxib, diclofenac).
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: Inform your doctor if you have Asthma/Allergies, Pheochromocytoma (Risk of severe hypertension), Congestive Heart Failure, Multiple Myeloma, or Myasthenia Gravis before administration of Diatrizoate Meglumine+diatrizoate Sodium.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
consult your doctorIt is unknown whether alcohol interacts with Diatrizoate Meglumine+diatrizoate Sodium. However, avoid alcohol consumption while treatment with Diatrizoate Meglumine+diatrizoate Sodium to prevent unpleasant side effects.
Pregnancy
consult your doctorThere is no adequate information on whether Diatrizoate Meglumine+diatrizoate Sodium affects pregnancy. Please inform your doctor if you are pregnant before receiving Diatrizoate Meglumine+diatrizoate Sodium to evaluate potential risks and benefits.
Breast Feeding
cautionDiatrizoate Meglumine+diatrizoate Sodium should be administered with caution in breastfeeding mothers as it may be excreted into breast milk and may pose risks to nursing infants. It is advised to temporarily stop for 24 hours after administration. Please consult your doctor for further guidance.
Driving
cautionSome individuals may experience dizziness after administration of Diatrizoate Meglumine+diatrizoate Sodium. If you experience this symptom during treatment, do not drive a vehicle or operate heavy machinery.
Liver
cautionDiatrizoate Meglumine+diatrizoate Sodium should be used with caution in patients with liver disease, as impaired liver function may affect its excretion and metabolism. Therefore, please inform your doctor before administration of Diatrizoate Meglumine+diatrizoate Sodium to evaluate potential risks and benefits.
Kidney
cautionDiatrizoate Meglumine+diatrizoate Sodium should be used with caution in patients with renal impairment, as delayed excretion may increase the risk of toxicity. Therefore, please inform your doctor before administering the Diatrizoate Meglumine+diatrizoate Sodium to assess kidney function and minimize potential risks.
Children
safe if prescribedDiatrizoate Meglumine+diatrizoate Sodium is safe to be used in children. However, dose adjustments may be needed based on your child's age and weight. Please consult the doctor for more information.
Habit Forming
Diet & Lifestyle Advise
- Drink plenty of water to stay hydrated before and after the procedure to help flush the contrast agent from your body and reduce the risk of kidney strain.
- Follow your doctor’s instructions on fasting. Some procedures may require you to avoid food or drink for a few hours beforehand.
- Alcohol and caffeine can contribute to dehydration, so it's best to limit their intake before and after administration of Diatrizoate Meglumine+diatrizoate Sodium.
- Avoid strenuous activities for a few hours if you feel weak or lightheaded after the procedure.
Special Advise
Diatrizoate Meglumine+diatrizoate Sodium should not be administered intrathecally (into the spinal canal), as this may lead to severe and potentially life-threatening complications.
Patients Concern
Disease/Condition Glossary
Diagnostic imaging procedure: A diagnostic imaging procedure that produces images of the inside of the body using X-rays and computer technologies. It comprehensively views any body portion, including muscles, organs, and blood vessels. It helps doctors diagnose and treat a wide range of medical disorders.
FAQs
Diatrizoate Meglumine+diatrizoate Sodium belongs to the group of medications called radiopaque contrast agents. It is used to enhance the quality of X-ray and fluoroscopic imaging of the gastrointestinal tract, blood vessels, urinary tract, and other internal structures for accurate diagnosis.
Diatrizoate Meglumine+diatrizoate Sodium is a combination medication that contains diatrizoate meglumine and diatrizoate sodium. These are iodinated contrast agents that effectively work by absorbing X-rays due to their high iodine content, making targeted organs or blood vessels appear opaque for clearer imaging. Being water soluble, they mix with body fluids, enhancing contrast in X-rays, CT scans, and fluoroscopy for accurate diagnosis.
Diatrizoate Meglumine+diatrizoate Sodium may cause dizziness in some of the individuals. Therefore, avoid driving or operating heavy machinery after receiving Diatrizoate Meglumine+diatrizoate Sodium until you know how it affects you.
The common side effects of Diatrizoate Meglumine+diatrizoate Sodium include nausea and flushing. Most of these side effects will resolve gradually over time and do not require medical attention. However, consult the doctor if you experience these side effects persistently.
